Previous Article | Next Article 
Infection and Immunity, January 2001, p. 613-616, Vol. 69, No. 1
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.613-616.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differential Interleukin-8 Response of Intestinal
Epithelial Cell Line to Reactogenic and Nonreactogenic Candidate
Vaccine Strains of Vibrio cholerae
Boris L.
Rodríguez,1,*
Armando
Rojas,2
Javier
Campos,1
Talena
Ledon,1
Edgar
Valle,1
William
Toledo,1 and
Rafael
Fando1
Departamento de Genética, Centro
Nacional de Investigaciones
Científicas,1 and Laboratorio de
Farmacología, Centro de Química
Farmacéutica,2 La Habana, Cuba
Received 18 April 2000/Returned for modification 16 June
2000/Accepted 25 October 2000
 |
ABSTRACT |
In this study, we analyzed whether attachment of Vibrio
cholerae vaccine strains to human intestinal epithelial cells can induce an interleukin-8 (IL-8) response. The IL-8 transcripts were
detected by PCR amplification of reverse-transcribed mRNA, and the gene
product secretion was measured by an enzyme-linked immunosorbent assay.
Infection of monolayers of the undifferentiated HT29-18N2 cell line
with reactogenic (JBK70 and 81) and nonreactogenic (CVD103HgR and 638)
vaccine strains of V. cholerae resulted in markedly higher
IL-8 expression by epithelial cells exposed to reactogenic strains than
by cells exposed to the nonreactogenic strains. Additionally,
epithelial cells produced IL-8 transcripts following stimulation with
cholera vaccine strains in a concentration-dependent manner. These
results represent a new insight into the inflammatory component of
reactogenicity and could be used as a predictive marker of vaccine
reactogenicity prior to human testing.
 |
TEXT |
Cholera is traditionally considered
to be a noninflammatory diarrheal disease caused by Vibrio
cholerae serogroups O1 and O139 (10). Several groups
of investigators have constructed a wide range of live attenuated
V. cholerae O1 and O139 strains by deleting the CTX
genes
in order to immunize against cholera (2, 5, 9, 11, 16,
19). However, many of these strains have shown residual adverse
properties (reactogenicity) in volunteer studies (1, 12, 22,
23). The cellular basis of reactogenicity is not clear, but
there is some evidence of an intestinal inflammatory response. It was
postulated that close proximity or contact of bacterial cells to the
apical surface of the intestinal epithelium causes reactogenicity, due
to the induction of a local inflammatory response; this theory was
based on the lower reactogenicity observed for nonmotile mutants of
V. cholerae compared with parental motile vaccine strains in
volunteer studies (15). Furthermore, oral vaccination with
CVD110, a reactogenic strain, produced copious amounts of lactoferrin
and increased interleukin-8 (IL-8) levels in the stool of volunteers,
while a nonreactogenic strain (CVD103HgR) did not (21).
The proinflammatory cytokine IL-8 is a potent chemoattractant for
polymorphonuclear leukocytes and T lymphocytes (17).
Polymorphonuclear leukocytes, which are found in large numbers in
inflammatory diarrheas (6, 20), can induce chloride secretion similar to that seen in toxigenic secretory diarrhea illnesses (14) and could play an important role in the
diarrhea seen with live attenuated cholera vaccine strains. On the
other hand, epithelial cells infected with several invasive and some noninvasive enteric pathogens produced an IL-8 response
(8). However, the induction of proinflammatory signals by
the attachment of V. cholerae strains to intestinal
epithelial cell lines has not been investigated. Here, we examined the
impact of attachment of reactogenic and nonreactogenic live cholera
vaccine strains to human intestinal epithelial cells on the IL-8
response by using the undifferentiated HT29-18N2 cell line
(7), a clone derived from the HT29 human adenocarcinoma
cell line. This clone, when maintained in high-glucose Dulbecco's
modified medium supplemented with fetal serum, does not produce mucus
and mainly remains in the form of columnar enterocytes
(18).
Strains, cell cultures, and infection protocol.
The V. cholerae strains used in this work are summarized in Table
1 and were grown as semiconfluent streaks
on Luria-Bertani agar. The HT29-18N2 cell line was provided by Tom E. Phillips (Department of Molecular Microbiology and Immunology,
University of Missouri, Columbia) and was maintained in a high-glucose
Dulbecco's modified medium supplemented with 10% fetal calf serum,
penicillin-streptomycin (10 U and 10 µg per ml), and amphotericin B
(0.5 µg/ml), hereafter referred to as complete medium. The cells were
incubated at 37°C in complete medium in an atmosphere of 5%
CO2. For all experiments, undifferentiated HT29-18N2 cells
were used to avoid mucus interference with adherence for all strains
assayed. Attachment of V. cholerae vaccine strains to the
intestinal epithelial cell line was essentially determined as described
previously (3). For IL-8 mRNA and gene product detection,
HT29-18N2 cells were seeded at 2 × 104 to 3 × 104 cells/cm2 onto 25-mm-diameter coverglasses
in six-well tissue culture plates in complete medium and incubated at
37°C in 5% CO2 until confluent. Twenty-four hours before
stimulation, the cell cultures were washed and maintained in fresh
complete medium without fetal calf serum. Duplicate coverglasses were
exposed to 106 to 107 CFU of each cholera
vaccine strain for 30 min, washed three times, transferred to fresh
Dulbecco's medium, and incubated for up to 8 h. In
dose-dependency experiments, the V. cholerae inoculum size
ranged from 104 to 107 CFU/well and RNA
extractions were performed 4 h postinfection.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Adherence of different V. cholerae vaccine
strains to the undifferentiated HT29-18N2 colonic epithelial cell line
|
|
RNA extraction, RT-PCR analysis, and cytokine assay.
Total
cellular RNA was extracted 0.5, 2, 4, and 8 h after challenge of
the epithelial cells with the different V. cholerae vaccine
strains by using the acid guanidinium thiocyanate-phenol-chloroform method (4). First-strand cDNA synthesis was performed by
using 1.5 µg of each purified RNA primed with 2 pmol of oligo(dT)
primer in a 20-µl reaction volume. Reverse transcriptions (RTs) were made by using the Reverse Transcription system (Promega, Madison, Wis.). Qualitative PCR analysis was performed with 1 µl of each cDNA
in a 50-µl reaction volume containing 0.2 mM deoxynucleoside triphosphate, 2 mM Mg2+, 0.5 µM concentrations of each
sense and antisense primer, and 1.25 U of Taq DNA
polymerase. All reagents for PCR amplification were purchased from
Boehringer (Mannheim, Germany). The PCR profile included a 94°C
denaturalization for 5 min, followed by 30 cycles of denaturalization
at 94°C for 1 min, annealing at 60°C for 1 min, extension at 72°C
for 2 min, and a final extension at 72°C for 10 min. The primers used
and the molecular sizes of the corresponding products were as follows:
-actin sense (5' GTG GGG CGC CCC AGG CAC CA 3') and antisense (5'
CTC CTT AAT GTC ACG CAC GAT TTC 3') (548 bp); IL-8 sense (5' ATG ACT
TCC AAG CTG GCC GTG 3') and antisense (5' TTA TGA ATT CTC AGC CCT CTT
CAA AAA CTT CTC 3') (302 bp). The IL-8 concentration was determined at
0.5, 2, 4, and 8 h postinfection in culture supernatants of
undifferentiated HT29-18N2 cells stimulated with reactogenic and
nonreactogenic cholera vaccine strains by the Quantikine enzyme-linked
immunosorbent assay (R & D Systems, Minneapolis, Minn.), with a
detection limit of less than 10 pg/ml. Both the RT-PCR analysis and
cytokine assay used unstimulated epithelial cell cultures as controls.
Tumor necrosis factor alpha (TNF-
)-treated epithelial cells were
used as positive controls for IL-8 stimulation.
Adherence of
V. cholerae vaccine strains to undifferentiated
HT29-18N2 cells was evaluated at 0.5, 2, 4, and 8 h postinfection,
and no significant (
P < 0.05) differences were
observed among
the cholera vaccine strains tested at all times assayed
(Table
1). Epithelial cell viability was higher than 95% within 8 h,
but longer times were not analyzed due to drastic changes in cell
morphology and low cell viability (less than 80%). The time course
of
IL-8 mRNA expression in epithelial cells after exposure to
cholera
vaccine strains was examined. In unstimulated cells no
IL-8 transcripts
were detected, while in TNF-

-treated cells a
strong IL-8 mRNA
expression was seen in 4 h (data not shown).
Amplification of the
same cDNAs with primers for

-actin demonstrated
that the expression
of the transcripts for this constitutive protein
was unaffected in all
samples tested. The IL-8 mRNA induction
by strain JBK70 became evident
at 2 h and increased for up to
8 h (Fig.
1); similar results were observed for
strain 81, except
that IL-8 mRNA was evident 1.5 h earlier (Fig.
1). On the other
hand, the nonreactogenic strains CVD103HgR and 638 also induced
IL-8 mRNA within 2 h which also increased for up to
8 h (Fig.
1). Strikingly, IL-8 mRNA expression in the
nonreactogenic strains
was, at all sampling times, markedly lower than
that induced by
strain JBK70 or 81. Increases in IL-8 mRNA were
dependent on inoculum
size, as demonstrated in dose-dependency
experiments for both
reactogenic and nonreactogenic strains, with lower
levels of transcript
expression in the latter (Fig.
2). Supernatants were collected
from
V. cholerae-infected confluent monolayers and IL-8 secretion
was measured by enzyme-linked immunosorbent assay. Unstimulated
cells
did not produce detectable levels of IL-8 (i.e., levels
were below 10 pg/ml), while TNF-

induced potent secretion of
the IL-8 gene product
within 4 h (Table
2). Both
reactogenic
strains (JBK70 and 81) induced secretion of IL-8, starting
at
4 h (Table
2). In contrast, no IL-8 was detected when
epithelial
cells were exposed to 638, while the IL-8 gene product was
only
detectable for CVD103HgR at 8 h (Table
2).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 1.
Time course of IL-8 mRNA induction in undifferentiated
HT29-18N2 colonic epithelial cells by reactogenic and nonreactogenic
cholera vaccine strains. Data shown are from a representative gel
electrophoresis of three independent RT-PCR amplification products of
-actin and IL-8 mRNAs from undifferentiated HT29-18N2 epithelial
cells, after stimulation with four V. cholerae vaccine
strains at various time intervals from 0 to 8 h. Numbers under
each panel represent densitometry values and are expressed in arbitrary
units. Sizes are indicated in base pairs (bp).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Dose-dependency experiments for IL-8 mRNA induction in
undifferentiated HT29-18N2 colonic epithelial cells by reactogenic and
nonreactogenic cholera vaccine strains. Data shown are from a
representative gel electrophoresis of three independent RT-PCR
amplification products of -actin and IL-8 mRNAs from
undifferentiated HT29-18N2 epithelial cells, after 4 h of
stimulation with two V. cholerae vaccine strains; inoculum
size ranged from 104 to 107 CFU/well. Numbers
under each panel represent densitometry values and are expressed as
arbitrary units. Sizes are indicated in base pairs (bp).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Secretion of IL-8 by the undifferentiated HT29-18N2 cell
line exposed to reactogenic or nonreactogenic cholera vaccine strains
|
|
Chemokines belonging to the C-X-C intercrine family of cytokines, such
as IL-8, play a major role in mobilizing cellular defense
mechanisms to
eliminate pathogens by recruiting and activating
neutrophils and T
cells (
17). Neutrophils are a protagonist
cell type
involved during the earlier steps of inflammatory reactions,
with a
capacity to interact with both epithelial and endothelial
cells as well
as an ability to produce a wide range of mediators.
As IL-8 and other
proinflammatory cytokines secreted by epithelial
cells may be the
initial signals for an acute inflammatory response
following bacterial
invasion of mucosal surfaces (
8), we sought
to develop an
in vitro model for IL-8 induction in intestinal
epithelial cells,
challenged with different
V. cholerae vaccine
strains, to
characterize this host-vaccine interaction. Our results
demonstrated
that JBK70, a reactogenic strain used in North American
and Cuban
volunteer studies (
1,
12) and 81, a highly reactogenic
strain used in Cuban volunteers (unpublished data), induced a
markedly
higher IL-8 response in terms of both mRNA and protein
levels in the
undifferentiated HT29-18N2 cell line than the response
produced by the
nonreactogenic strains, CVD103HgR and 638 (
1,
13). The
differential IL-8 response obtained here for reactogenic
and
nonreactogenic strains is in agreement with the reactogenic
hypothesis
of Mekalanos et al. (
15) and with the recent report
of
Silva et al. (
21) in which the stools of volunteers
colonized
with CVD110 contained increased levels of this cytokine.
Taken
together, these findings support the idea that IL-8 may be an
important mediator in the proposed inflammatory response to reactogenic
cholera vaccine strains, suggesting a potential role for neutrophils
in
the diarrhea seen with live attenuated
V. cholerae vaccine
strains in clinical trials. Further studies using other reactogenic
and
nonreactogenic
V. cholerae vaccine strains will be needed
to
evaluate whether the IL-8 response seen in HT29-18N2 cells
could be
used as a predictive marker of vaccine reactogenicity
prior to human
testing. Experiments are being conducted to determine
the expression of
other proinflammatory and anti-inflammatory
cytokines by this
intestinal epithelial cell line in response
to the same
stimuli.
 |
ACKNOWLEDGMENTS |
We are grateful to Tom E. Philips and Richard A. Finkelstein for
the HT29-18N2 cell line and to Arlenis M. Guerra for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento de
Genética, CNIC, Ave. 25 y 158, Cubanacan, Playa, P.O. Box
6412, La Habana, Cuba. Phone: (537) 21 80 66. Fax: (537) 28 04 97. E-mail: boris{at}biocnic.cneuro.edu.cu.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Benitez, J. A.,
L. Garcia,
A. Silva,
H. Garcia,
R. Fando,
B. Cedre,
A. Perez,
J. Campos,
B. L. Rodriguez,
J. L. Perez,
T. Valmaseda,
O. Perez,
A. Perez,
M. Ramirez,
T. Ledon,
M. D. Yidy,
M. Lastre,
L. Bravo, and G. Sierra.
1999.
Preliminary assessment of safety and immunogenicity of a new CTX -negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.
Infect. Immun.
67:539-545[Abstract/Free Full Text].
|
| 2.
|
Benitez, J. A.,
A. Silva,
B. L. Rodriguez,
R. Fando,
J. Campos,
A. Robert,
H. Garcia,
L. Garcia,
J. L. Perez,
R. Oliva,
C. A. Torres, and T. Ledon.
1996.
Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
Arch. Med. Res.
27:275-283[Medline].
|
| 3.
|
Benitez, J. A.,
R. G. Spelbrink,
A. Silva,
T. E. Phillips,
C. M. Stanley,
M. Boesman-Finkelstein, and R. A. Finkelstein.
1997.
Adherence of V. cholerae to cultured differentiated human intestinal epithelial cells: an in vitro colonization model.
Infect. Immun.
65:3474-3477[Abstract].
|
| 4.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 5.
|
Coster, T. S.,
K. P. Killeen,
M. K. Waldor,
D. T. Beattle,
D. R. Spriggs,
J. R. Kenner,
A. Trofa,
J. C. Sadoff,
J. J. Mekalanos, and D. N. Taylor.
1995.
Safety, immunogenicity and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypes.
Lancet
345:949-952[CrossRef][Medline].
|
| 6.
|
Guerrant, R. L.,
V. Araujo,
E. Suares,
K. Kotloff,
A. A. M. Lima,
W. H. Cooper, and A. G. Lee.
1992.
Measurement of fecal lactoferrin as a marker of fecal leukocytes.
J. Clin. Microbiol.
30:1238-1242[Abstract/Free Full Text].
|
| 7.
|
Huet, C.,
L. Sahuquillo-Merino,
E. Condrier, and S. Louvard.
1987.
Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT29) provide new models for cell polarity and terminal differentiation.
J. Cell Biol.
105:345-358[Abstract/Free Full Text].
|
| 8.
|
Kagnoff, M. F., and L. Eckmann.
1997.
Perspectives series: host/pathogen interactions.
J. Clin. Investig.
100:6-10[Medline].
|
| 9.
|
Kaper, J. B.,
H. Lockman,
M. M. Baldini, and M. M. Levine.
1984.
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.
Nature
308:655-658[CrossRef][Medline].
|
| 10.
|
Kaper, J. B.,
J. G. Morris, Jr., and M. M. Levine.
1995.
Cholera.
Clin. Microbiol. Rev.
8:48-86[Abstract].
|
| 11.
|
Ketley, J. M.,
J. Michalski,
J. E. Galen,
M. M. Levine, and J. B. Kaper.
1993.
Construction of genetically marked Vibrio cholerae O1 vaccine strains.
FEMS Microbiol. Lett.
111:15-22[CrossRef][Medline].
|
| 12.
|
Levine, M. M.,
J. B. Kaper,
D. Herrington,
G. Losonsky,
J. G. Morris,
M. I. Clements,
R. E. Black,
B. Tall, and R. Hall.
1988.
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
Infect. Immun.
56:161-167[Abstract/Free Full Text].
|
| 13.
|
Levine, M. M.,
J. B. Kaper,
D. Herrington,
J. Ketley,
G. Losonsky,
C. O. Tacket,
B. Tall, and S. Cryz.
1988.
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR.
Lancet
ii:467-470.
|
| 14.
|
Madara, J. L.,
T. W. Patapoff,
B. Gillece-Castro,
S. P. Colgan,
C. A. Parkos,
C. Delp, and R. J. Mrsny.
1993.
5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers.
J. Clin. Investig.
91:2320-2325.
|
| 15.
|
Mekalanos, J. J.,
M. K. Waldor,
C. L. Gardel,
T. S. Coster,
J. Kenner,
K. P. Killeen,
D. T. Beattie,
A. Trofa,
D. N. Taylor, and J. C. Sadoff.
1995.
Live cholera vaccines: perspectives on their construction and safety.
Bull. Inst. Pasteur
93:255-262[CrossRef].
|
| 16.
|
Michalski, J.,
J. E. Galen,
A. Fasano, and J. B. Kaper.
1993.
Vibrio cholerae CVD110: a live attenuated El Tor vaccine strain.
Infect. Immun.
61:4462-4468[Abstract/Free Full Text].
|
| 17.
|
Oppenheim, J. J.,
C. O. C. Zachariae,
N. Mukaida, and K. Matsushima.
1991.
Properties of a novel proinflammatory supergene intercrine cytokine family.
Annu. Rev. Immunol.
9:617-648[Medline].
|
| 18.
|
Phillips, T. E.,
R. Ramos, and S. L. Duncan.
1995.
Differentiation of the HT29-18N2 human adenocarcinoma cell line in a protein-free medium: effect of insulin and transferrin.
In Vitro Cell. Dev. Biol.
31:421-423.
|
| 19.
|
Robert, A.,
A. Silva,
J. A. Benitez,
B. L. Rodriguez,
R. Fando,
J. Campos,
D. K. Sengupta,
M. Boesman-Finkelstein, and R. A. Finkelstein.
1996.
Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocelum endoglucanase A.
Vaccine
14:1517-1522[CrossRef][Medline].
|
| 20.
|
Silletti, R. P.,
A. G. Lee, and E. Ailey.
1996.
Role of stool screening test in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens.
J. Clin. Microbiol.
34:1161-1165[Abstract].
|
| 21.
|
Silva, T. N. J.,
M. A. Schleupner,
C. O. Tacket,
T. S. Steiner,
J. B. Kaper,
R. Edelman, and R. Guerrant.
1996.
New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and O139 Vibrio cholerae.
Infect. Immun.
64:2362-2364[Abstract].
|
| 22.
|
Tacket, C. O.,
G. Losonski, and J. P. Nataro.
1993.
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a ctxA zot ace derivative of El Tor Ogawa Vibrio cholerae.
J. Infect. Dis.
168:1536-1540[Medline].
|
| 23.
|
Taylor, D. N.,
K. P. Killeen,
D. C. Hack,
J. R. Kenner,
T. S. Coster,
D. T. Beattie,
J. Ezzell,
T. Hyman,
A. Trofa,
M. J. Sjognen,
A. Friedlander,
J. J. Mekalanos, and J. C. Sadoff.
1994.
Development of live, oral, attenuated vaccine against El Tor cholera.
J. Infect. Dis.
170:1518-1523[Medline].
|
Infection and Immunity, January 2001, p. 613-616, Vol. 69, No. 1
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.613-616.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Harrison, L. M., Rallabhandi, P., Michalski, J., Zhou, X., Steyert, S. R., Vogel, S. N., Kaper, J. B.
(2008). Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-{kappa}B Activation. Infect. Immun.
76: 5524-5534
[Abstract]
[Full Text]
-
Puthia, M. K., Lu, J., Tan, K. S. W.
(2008). Blastocystis ratti Contains Cysteine Proteases That Mediate Interleukin-8 Response from Human Intestinal Epithelial Cells in an NF-{kappa}B-Dependent Manner. Eukaryot Cell
7: 435-443
[Abstract]
[Full Text]
-
Ghosh, A., Saha, D. R., Hoque, K. M., Asakuna, M., Yamasaki, S., Koley, H., Das, S. S., Chakrabarti, M. K., Pal, A.
(2006). Enterotoxigenicity of Mature 45-Kilodalton and Processed 35-Kilodalton Forms of Hemagglutinin Protease Purified from a Cholera Toxin Gene-Negative Vibrio cholerae Non-O1, Non-O139 Strain.. Infect. Immun.
74: 2937-2946
[Abstract]
[Full Text]
-
Stokes, N. R., Zhou, X., Meltzer, S. J., Kaper, J. B.
(2004). Transcriptional Responses of Intestinal Epithelial Cells to Infection with Vibrio cholerae. Infect. Immun.
72: 4240-4248
[Abstract]
[Full Text]
-
Zhou, X., Gao, D. Q., Michalski, J., Benitez, J. A., Kaper, J. B.
(2004). Induction of Interleukin-8 in T84 Cells by Vibrio cholerae. Infect. Immun.
72: 389-397
[Abstract]
[Full Text]